Creon 00032-1212-13

Generic: Pancrelipase

Package NDC

00032-1212-13

Manufacturer: Abbvie Inc.
Dosage Form: Capsule, Delayed Release Pellets
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: April 30, 2009
Listing Expires: December 31, 2026
Application: BLA020725

Need to source Creon? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Pancrelipase Amylase	60000 [USP'U]/1
Pancrelipase Lipase	12000 [USP'U]/1
Pancrelipase Protease	38000 [USP'U]/1

Selected Package

00032-1212-13Selected

1 BOTTLE in 1 CARTON (0032-1212-13) / 100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE

Other packages for this product(2)

00032-1212-01

100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0032-1212-01)

View →

00032-1212-07

250 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0032-1212-07)

View →